Filters
Sell-side analysts and investors visit Hikma Casablanca site
Press Release, Corporate 14 November 2024
New
Celebrating Global Biosimilars Week: Hikma champions access to essential medicines for patients in the MENA region
Story, Business Development 12 November 2024
New
Hikma continues strong strategic execution and reiterates guidance
Press Release, Financial Results 07 November 2024
New
Hikma's leadership receives prestigious recognitions in 2024
Story, Leadership 22 October 2024
Empowering lives - Hikma’s regional blood donation drives across MENA
Story, Responsibility 21 October 2024
New
Hikma celebrates 40 years of Hatch-Waxman drug savings
Insight, Corporate 30 September 2024
New
Hikma: where our purpose inspires our people
Insight, Corporate 23 September 2024
New
Hikma launches Foscarnet Sodium Injection, in the US
Press Release, Product 23 September 2024
Hikma completes Xellia acquisition
Press Release, Corporate 10 September 2024
Hikma launches Clindamycin in 5% Dextrose Injection in the US
Press Release, Product 03 September 2024
New
Bringing Better Health Within Reach: Improving access to medicine as the partner of choice in MENA
Insight, Corporate 28 August 2024
New
Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fenta...
Press Release, Product 20 August 2024
New
KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months
Press Release, Product 15 August 2024
Hikma delivers strong H1 performance and upgrades Group guidance
Press Release, Financial Results 08 August 2024
New
Hikma Pharmaceuticals: how our three businesses work together to improve health
Insight, Corporate 31 July 2024
You have viewed 15 of 449 results